California Drug-Specific SJS Claims: Getting Justice for Severe Drug Reactions

What Is SJS/TEN and Why It Matters in Drug Cases

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe immune-mediated skin and mucous membrane reactions that can lead to blistering, skin detachment, eye injury, infection, and long-term complications. Medicines are among the most commonly reported triggers.¹ In drug cases, core legal questions include what risks were known or knowable, whether warnings were adequate, and whether manufacturers or healthcare providers met their duties.

Drugs Commonly Associated with SJS/TEN

Medical references and safety communications have reported SJS/TEN following use of certain medications, including:

• Antibiotics (for example, sulfonamides)
• Anti-seizure medicines (for example, carbamazepine and lamotrigine)
• Gout medication (for example, allopurinol)
• Nonsteroidal anti-inflammatory drugs (NSAIDs; risk varies by agent)
• Other agents such as acetaminophen have also been linked to rare, serious skin reactions

Representative safety and reference sources include the Merck Manual overview and FDA communications/labels.^{1, 2, 3, 4} Not every patient will react, and causation is highly fact-specific. Do not start, stop, or change any medication without medical advice.

Potential Legal Theories in California

Depending on the facts, California plaintiffs may pursue:

• Strict liability—failure to warn and manufacturing defect claims against drug manufacturers; design-defect strict liability for prescription drugs is generally barred under California law.⁵
• Negligence (including negligent failure to warn), with California’s learned intermediary doctrine focusing the manufacturer’s duty to warn on prescribing clinicians who then advise patients.⁶
• Breach of warranty claims, depending on labeling and representations.
• Professional negligence against healthcare providers where prescribing, monitoring, or response to adverse reactions fell below the standard of care.

California also recognizes, in appropriate circumstances, potential liability of a brand-name manufacturer for inadequate warnings that harm a patient who ingested a generic equivalent (sometimes called innovator liability).⁷

Who May Be Liable

Potentially responsible parties can include brand-name manufacturers, distributors, pharmacies, and healthcare providers. Claims against generic manufacturers are often limited by federal preemption, which has barred many failure-to-warn and design-defect claims against generics under federal law.^{8, 9} The existence and scope of a pharmacist’s duty to warn generally is limited in California and depends on the circumstances.¹⁰

Evidence to Preserve for an SJS/TEN Claim

• Complete medication list with start/stop dates, doses, prescribers, pharmacies, and lot numbers (if available)
• Packaging, receipts, Medication Guides, and patient information leaflets
• Medical records (ER notes, inpatient records, dermatology/ophthalmology consults, biopsy reports, labs, discharge summaries)
• Photographs of the rash and eye involvement over time
• Communications with healthcare providers and insurers
• Work/school records showing time off and accommodations

Causation and Expert Support

SJS/TEN litigation typically requires expert testimony regarding medical causation, the standard of care, labeling adequacy, and regulatory history. A careful differential diagnosis and timeline are often critical to link the reaction to a specific medication. Authoritative medical references (for example, Merck Manual; MedlinePlus) can help frame medical issues.^{1, 11}

Damages You May Be Able to Recover

Depending on the proof and applicable claims, recoverable damages may include past/future medical expenses (hospitalization, wound and eye care, rehabilitation), lost income and diminished earning capacity, pain and suffering, disfigurement, and—in appropriate cases—punitive damages against manufacturers for conduct meeting California’s statutory standard of malice, oppression, or fraud.¹² Families may have wrongful death or survivor claims in the event of a fatal reaction.

Deadlines and Why Timing Matters

California imposes strict deadlines. Some common examples include:

• General personal injury and wrongful death: typically two years from injury/death (subject to accrual and tolling rules).¹³
• Medical malpractice: generally one year from discovery or three years from the date of injury, whichever occurs first, with statutory exceptions.¹⁴
• Claims involving public entities often require a government claim in as little as six months.¹⁵

How Our California Firm Can Help

We investigate potential drug-related SJS/TEN claims, coordinate expert review, gather medical and pharmacy evidence, evaluate labeling and regulatory history, identify responsible parties, and pursue compensation through negotiation or litigation. We handle cases statewide and collaborate with your treating physicians to understand long-term needs. Contact us to discuss your options.

FAQs

What if I took a generic version of the drug?

Many claims against generic manufacturers are limited by federal preemption, but California may allow claims against the brand-name manufacturer for inadequate warnings that foreseeably harmed generic users in certain circumstances.^{7, 8}

How long do I have to file?

Deadlines vary by claim type and facts. Some are as short as six months for claims involving public entities; others are typically one to two years. Speak with a lawyer promptly to evaluate your specific deadlines.^{13, 14, 15}

Should I stop taking the suspected medication?

Do not change medications without medical advice. Seek emergency care and follow your physician’s instructions.

Do I have a claim if warnings listed rash as a risk?

Possibly. Adequacy of warnings, their timing, and whether the warning reached the prescribing clinician under the learned intermediary doctrine are fact-specific issues.

What compensation might be available?

Medical costs, lost income, pain and suffering, disfigurement, and in appropriate cases punitive damages, depending on proof and California law.¹²

What’s the next step?

Gather evidence, document your timeline, and speak with a California attorney. Contact us for a free consultation.

Key Legal Principles and Sources

• Prescription drug design-defect strict liability is generally barred; warnings and manufacturing-defect theories remain.⁵
• Learned intermediary doctrine and failure-to-warn principles in California product cases.⁶
• Innovator liability against brand manufacturers in certain generic-use scenarios.⁷
• Federal preemption limiting many claims against generic manufacturers.^{8, 9}
• Pharmacist duties are generally limited and fact-dependent.¹⁰

This content was last reviewed on 2025-09-23.

Disclaimer (California): This blog is for general informational purposes only and is not legal or medical advice. Reading it does not create an attorney-client relationship. Laws, regulations, and deadlines can change and vary by facts. If you are outside California, your laws may differ. Do not rely on this post for medical decisions—consult your healthcare provider. If you have a medical emergency, call 911. To get advice about your situation, contact a California attorney.